{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:57:58Z","timestamp":1785560278857,"version":"3.56.0"},"reference-count":41,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2026,7,31]]},"DOI":"10.1536\/ihj.26-096","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T22:10:55Z","timestamp":1785449455000},"page":"354-364","source":"Crossref","is-referenced-by-count":0,"title":["Joint Association of Hyperuricemia and Vitamin D Deficiency with Cardiovascular Disease Risk and All-Cause Mortality"],"prefix":"10.1536","volume":"67","author":[{"given":"Yingdong","family":"Han","sequence":"first","affiliation":[{"name":"Department of Family Medicine &amp; Division of General Internal Medicine, Department of Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases (Peking Union Medical College Hospital)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikai","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Family Medicine &amp; Division of General Internal Medicine, Department of Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases (Peking Union Medical College Hospital)"},{"name":"Eight-year Medical Doctor Program, Chinese Academy of Medical Sciences &amp; Peking Union Medical College"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menghui","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Family Medicine &amp; Division of General Internal Medicine, Department of Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases (Peking Union Medical College Hospital)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiange","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Family Medicine &amp; Division of General Internal Medicine, Department of Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases (Peking Union Medical College Hospital)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Family Medicine &amp; Division of General Internal Medicine, Department of Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases (Peking Union Medical College Hospital)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Family Medicine &amp; Division of General Internal Medicine, Department of Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases (Peking Union Medical College Hospital)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Family Medicine &amp; Division of General Internal Medicine, Department of Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases (Peking Union Medical College Hospital)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejun","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Family Medicine &amp; Division of General Internal Medicine, Department of Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, State Key Laboratory of Complex Severe and Rare Diseases (Peking Union Medical College Hospital)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Ndrepepa G. Uric acid and cardiovascular disease. Clinica Chimica Acta 2018; 484: 150-63.","DOI":"10.1016\/j.cca.2018.05.046"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Wen S, Arakawa H, Tamai I. Uric acid in health and disease: From physiological functions to pathogenic mechanisms. Pharmacol Ther 2024; 256: 108615.","DOI":"10.1016\/j.pharmthera.2024.108615"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Joosten LAB, Cri\u015fan TO, Bjornstad P, Johnson RJ. Asymptomatic hyperuricaemia: a silent activator of the innate immune system. Nat Rev Rheumatol 2020; 16: 75-86.","DOI":"10.1038\/s41584-019-0334-3"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Zhang M, Zhu X, Wu J, <i>et al<\/i>. Prevalence of Hyperuricemia Among Chinese Adults: Findings From Two Nationally Representative Cross-Sectional Surveys in 2015\u201316 and 2018\u201319. Front Immunol 2022; 12: 791983.","DOI":"10.3389\/fimmu.2021.791983"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011; 63: 3136-41.","DOI":"10.1002\/art.30520"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007\u20132016. Arthritis Rheum 2019; 71: 991-9.","DOI":"10.1002\/art.40807"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Dalbeth N, Gosling AL, Gaffo A, Abhishek A. Gout. Lancet 2021; 397: 1843-55.","DOI":"10.1016\/S0140-6736(21)00569-9"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Dalbeth N, Merriman TR, Stamp LK. Gout. Lancet 2016; 388: 2039-52.","DOI":"10.1016\/S0140-6736(16)00346-9"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Johnson RJ, Bakris GL, Borghi C, <i>et al<\/i>. Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation. Am J Kidney Dis 2018; 71: 851-65 (doi: 10.1053\/j.ajkd.2017.12.009).","DOI":"10.1053\/j.ajkd.2017.12.009"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Mandal AK, Mount DB. The Molecular Physiology of Uric Acid Homeostasis. Annu Rev Physiol 2015; 77: 323-45.","DOI":"10.1146\/annurev-physiol-021113-170343"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Du L, Zong Y, Li H, <i>et al<\/i>. Hyperuricemia and its related diseases: mechanisms and advances in therapy. Signal Transduct Target Ther 2024; 9: 212.","DOI":"10.1038\/s41392-024-01916-y"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Christakos S, Dhawan P, Verstuyf A, Verlinden L, Carmeliet G. Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects. Physiol Rev 2016; 96: 365-408.","DOI":"10.1152\/physrev.00014.2015"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ganji V, Zhang X, Tangpricha V. Serum 25-Hydroxyvitamin D Concentrations and Prevalence Estimates of Hypovitaminosis D in the U.S. Population Based on Assay-Adjusted Data,2. J Nutr 2012; 142: 498-507.","DOI":"10.3945\/jn.111.151977"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Zhao S, Qian F, Wan Z, Chen X, Pan A, Liu G. Vitamin D and major chronic diseases. Trends Endocrinol Metab 2024; 35: 1050-61.","DOI":"10.1016\/j.tem.2024.04.018"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Zhou A, Selvanayagam JB, Hypp\u00f6nen E. Non-linear Mendelian randomization analyses support a role for vitamin D deficiency in cardiovascular disease risk. Eur Heart J 2022; 43: 1731-9.","DOI":"10.1093\/eurheartj\/ehab809"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Sofianopoulou E, Kaptoge SK, Afzal S, <i>et al<\/i>. Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses. Lancet Diabetes Endocrinol 2024; 12: e2-e11.","DOI":"10.1016\/S2213-8587(23)00364-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Zhang R, Li B, Gao X, <i>et al<\/i>. Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies. Am J Clin Nutr 2017; 105: 810-9.","DOI":"10.3945\/ajcn.116.140392"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ma Z, Xiong T, Li Y, <i>et al<\/i>. The Inverted U-Shaped Association between Serum Vitamin D and Serum Uric Acid Status in Children and Adolescents: A Large Cross-Sectional and Longitudinal Analysis. Nutrients 2024; 16: 1492.","DOI":"10.3390\/nu16101492"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Chen W, Roncal-Jimenez C, Lanaspa M, <i>et al<\/i>. Uric acid suppresses 1 alpha hydroxylase in vitro and in vivo. Metabolism 2014; 63: 150-60.","DOI":"10.1016\/j.metabol.2013.09.018"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Han Y, Han K, Zhang Y, Zeng X. Serum 25-hydroxyvitamin D might be negatively associated with hyperuricemia in U.S. adults: an analysis of the National Health and Nutrition Examination Survey 2007\u20132014. J Endocrinol Invest 2022; 45: 719-29.","DOI":"10.1007\/s40618-021-01637-x"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Roth GA, Abate D, Abate KH, <i>et al<\/i>. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2018; 392: 1736-88.","DOI":"10.1016\/S0140-6736(18)32203-7"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Townsend N, Kazakiewicz D, Lucy Wright F, <i>et al<\/i>. Epidemiology of cardiovascular disease in Europe. Nat Rev Cardiol 2021; 19: 133-43.","DOI":"10.1038\/s41569-021-00607-3"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Sacks FM, Lichtenstein AH, Wu JHY, <i>et al<\/i>. Dietary Fats and Cardiovascular Disease: A Presidential Advisory From the American Heart Association. Circulation 2017; 136: e1-e23.","DOI":"10.1161\/CIR.0000000000000510"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol 2018; 16: 203-12.","DOI":"10.1038\/s41569-018-0119-4"},{"key":"25","unstructured":"25. Centers for Disease, Control, and Prevention. National Health and Nutrition Examination Survey. Available at: https:\/\/www.cdc.gov\/nchs\/nhanes\/. Accessed October 11, 2024."},{"key":"26","unstructured":"26. NCHS Ethics Review Board (ERB) Approval. Available at: https:\/\/www.cdc.gov\/nchs\/nhanes\/irba98.htm. Accessed October 15, 2024."},{"key":"27","unstructured":"27. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). National health and nutrition examination survey laboratory protocol. Standard Biochemistry Profile (BIOPRO_I). Available at: https:\/\/wwwn.cdc.gov\/nchs\/data\/nhanes\/2013-2014\/labmethods\/BIOPRO_H_MET_URIC_ACID.pdf. Accessed September 20, 2024."},{"key":"28","doi-asserted-by":"publisher","unstructured":"28. Sui X CT, Meriwether RA, Lobelo F, Blair SN. Uric acid and the development of metabolic syndrome in women and men. Metabolism 2008; 57: 845-52.","DOI":"10.1016\/j.metabol.2008.01.030"},{"key":"29","unstructured":"29. Centers for Disease Control and Prevention (CDC). National center for health Statistics (NCHS). National health and nutrition examination survey laboratory protocol.Vitamin D (VID_H). Available at: https:\/\/wwwn.cdc.gov\/nchs\/data\/nhanes\/2013-2014\/labmethods\/VID_H_MET.pdf. Accessed October 15, 2024."},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Holick MF, Binkley NC, Bischoff-Ferrari HA, <i>et al<\/i>. Evaluation, Treatment, and Prevention of Vitamin D Deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011; 96: 1911-30.","DOI":"10.1210\/jc.2011-0385"},{"key":"31","unstructured":"31. National Center for Health Statistics. NCHS Data Linked to NDI Mortality Files. Available at: https:\/\/www.cdc.gov\/nchs\/data-linkage\/mortality.htm. Accessed October 15, 2024."},{"key":"32","unstructured":"32. National Health and Nutrition Examination Survey. Tutorials. Module 3: Weighting. Available at: https:\/\/wwwn.cdc.gov\/nchs\/nhanes\/tutorials\/weighting.aspx. Accessed November 6, 2024."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Han Y, Xie T, Li Z, <i>et al<\/i>. Joint effect of hyperuricemia and severe vitamin D deficiency on all-cause and cardiovascular mortality among individuals with diabetes. J Nutr Biochem 2025; 146: 110083.","DOI":"10.1016\/j.jnutbio.2025.110083"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Feig DI, Kang D-H, Johnson RJ. Uric Acid and Cardiovascular Risk. N Engl J Med 2008; 359: 1811-21.","DOI":"10.1056\/NEJMra0800885"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Braga F, Pasqualetti S, Ferraro S, Panteghini M. Hyperuricemia as risk factor for coronary heart disease incidence and mortality in the general population: a systematic review and meta-analysis. Clin Chem Lab Med 2016; 54: 7-15.","DOI":"10.1515\/cclm-2015-0523"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Ponticelli C, Podest\u00e0 MA, Moroni G. Hyperuricemia as a trigger of immune response in hypertension and chronic kidney disease. Kidney Int 2020; 98: 1149-59.","DOI":"10.1016\/j.kint.2020.05.056"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Keech A, Wheeler JG, Juzwishin KDM, Eiriksdottir G, Gudnason V, Danesh J. Serum Uric Acid and Coronary Heart Disease in 9,458 Incident Cases and 155,084 Controls: Prospective Study and Meta-Analysis. PLoS Med 2005; 2: e76.","DOI":"10.1371\/journal.pmed.0020076"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Charoenngam N. Vitamin D and Rheumatic Diseases: A Review of Clinical Evidence. Int J Mol Sci 2021; 22: 10659.","DOI":"10.3390\/ijms221910659"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Lei H, Wei B, Dong X, <i>et al<\/i>. Association between serum vitamin D levels and cardiovascular disease risk in patients with hyperuricemia: A cross-sectional study. PLoS One 2026; 21: e0346141.","DOI":"10.1371\/journal.pone.0346141"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Jayachandran M, Qu S. Harnessing hyperuricemia to atherosclerosis and understanding its mechanistic dependence. Med Res Rev 2021; 41: 616-29.","DOI":"10.1002\/med.21742"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Sugimoto R, Watanabe H, Ikegami K, <i>et al<\/i>. Down-regulation of ABCG2, a urate exporter, by parathyroid hormone enhances urate accumulation in secondary hyperparathyroidism. Kidney Int 2017; 91: 658-70.","DOI":"10.1016\/j.kint.2016.09.041"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/67\/4\/67_26-096\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T04:14:13Z","timestamp":1785557653000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/67\/4\/67_26-096\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,31]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.26-096","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,31]]},"article-number":"26-096"}}